期刊文献+

IFN-λs与乙型肝炎及丙型肝炎抗病毒治疗的相关性 被引量:4

IFN-λs Correlation with Antiviral Treatment for Hepatitis B and C
下载PDF
导出
摘要 干扰素(IFN)α是目前一种对乙型肝炎病毒和丙型肝炎病毒感染比较有效的抗病毒治疗药物,但其不良反应限制了其应用范围。同时核苷(酸)类似物药物的耐药性目前已成棘手问题。在宿主对病毒的免疫反应中IFN-λs的作用已开始显现,深入理解IFN-λs对乙型肝炎和丙型肝炎的影响,有助于明确慢性病毒感染的机制,为临床抗病毒治疗提供新方法。现就IFN-λs与抗乙型肝炎和丙型肝炎的关系进行综述。 Interferon(IFN)α is a quite effective anti-viral medicine to HBV and HCV,however its adverse reaction has limited its application,and nucleoside analog′s drug resistance has become a tough problem.The function of IFN-λs in the host immune response to these viruses is beginning to be revealed.Deeper understanding of how IFN-λs influences HBV or HCV persistence is not only important for identifying the mechanisms of chronic virus infection,but also may lead to a new approach for clinical antiviral therapy.Here is to review the relationship between IFN-λs and antiviral treatment of HBV and HCV.
作者 刘明水 韦嘉
出处 《医学综述》 2012年第3期385-388,共4页 Medical Recapitulate
关键词 干扰素λs 乙型肝炎 丙型肝炎 抗病毒治疗 Interferon-λs Hepatitis B Hepatitis C Anti-viral treatment
  • 相关文献

参考文献30

  • 1Pagliacetti NE,Robek MD.Interferon-λ in the immune response to hepatitis B virus and hepatitis C virus[J].J Interferon Cytokine Res,2010,30(8):585-590. 被引量:1
  • 2Sheppard P,Kindsvogel W,Xu W,et al.IL-28,IL-29 and their class Ⅱ cytokine receptor IL-28R[J].Nature Immunol,2003,4(1):63-68. 被引量:1
  • 3Kotenko SV,Gallagher G,Baurin VV,et al.IFN-λs mediate antiviral protection though a distinct class Ⅱcytokine reptor complex[J].Natuare Immunol,2003,4(1):69-77. 被引量:1
  • 4Renauld JC.Class Ⅱ cytokine receptors and their ligands:key antiviral and inflammatory modulators[J].Nature Rev Immunol,2003,3(8):666-676. 被引量:1
  • 5Langhans B,Kupfer B,Braunschweiger I,et al.Interferon-lamda serum levels in hepatitis C[J].J Hepatol,2011,54(5):859-865. 被引量:1
  • 6Sommereyns C,Paul S,Staeheli P,et al.IFN-lambda(IFN-lambda)is expressed in a tissue-dependent fashion and primarily acts on epithelial cells in vivo[J].PLoS Pathog,2008,4(3):e1000017. 被引量:1
  • 7Lasfar A,Lewis-Antes A,Smirnov SV,et al.Characterization of the mouse IFN-λ ligand-receptor sysrem:IFN-λs exhibit antitumor activity against B16 melanoma[J].Cancer Res,2006,66(8):4468-4477. 被引量:1
  • 8Foy E,Li K,Sumpter R,et al.Control of antiviral defenses through hepatitis C virus disruption of retinoic acid-inducible gene-Ⅰ signal[J].Froc Natl Sci U S A,2005,102(8):2986-2991. 被引量:1
  • 9Foy E,Li K,Wang C,et al.Regulation of interferon regulatory factor-3 by the hepatitis C virus serine protease[J].Science,2003,300(5622):1145-1148. 被引量:1
  • 10Li K,Foy E,Ferreon JC,et al.Immune evasion by hepatitis C virus NS3/4A protease-mediated cleavage of the Too-like receptor 3 adaptor protein TRIF[J].Proc Natl Acad Sci U S A,2005,102(8):2992-2997. 被引量:1

同被引文献57

  • 1Ghany MG, Strader DB, Thomas DL, et al. Diagnosis, management, and treatment of hepatitis C: an update. Hepatology, 2009,49(4) : 1335-1374. 被引量:1
  • 2Bruix J, Sherman M. Management of hepatocellular carcinoma: an update. Hepatology ,2010,53 ( 3 ) : 1020-1022. 被引量:1
  • 3Manns MP, MeHutchison JG, Gordon S, et al. Peginterfem alpha- 2b plus ribavirin compared to interferon alpha-2b plus ribavirin for the treatment of chronic hepatitis C. A randomized trail. Lancet, 2001,358(9286) :958-965. 被引量:1
  • 4Fied MW, Schiffman MI, Reddy R, et al. Peginterferon alpha-2a plus ribavirin for chronic hepatitis C virus infection. N Eng J Med, 2002,347 ( 13 ) :975-982. 被引量:1
  • 5Wohnsland A, Hofmann WP, Sarrazin C. Viral determinants of resistance to treatment in patients with hepatitis C. Clin Microbiol Rev ,2007,20( 1 ) :23-38. 被引量:1
  • 6Ge D, Fellay J, Thompson AJ, et al. Genetic variation in IL28B predicts hepatitis C treatment-induced viral clearance. Nature,2009,461 (7262) :399-401. 被引量:1
  • 7Kotenko SV, Gallagher G, Baurin VV, et al. lFN-lambdas mediate antiviral protection through a distinct class 1I cytokine reeeptor complex. Nat Immunol,2003,4( 1 ) :69-77. 被引量:1
  • 8Sheppard P, Kindsvogel W, Xu W, et al. IL-28, IL-29 and their class II cytokine receptor IL-28R. Nat Immunol, 2003,4 ( 1 ) : 63-68. 被引量:1
  • 9Renauid JC. Class 1I cytokine receptors and their |igands: key antiviral and inflammatory modulators. Nature Rev Immunol,2003,3 (8) :666-676. 被引量:1
  • 10Langhans B, Kupfer B, Braunschweiger I, et al. Interferon-lambda serum levels in hepatitis C. J Hepatol,2011,54(5 ) :859-865. 被引量:1

引证文献4

二级引证文献13

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部